Abstract

Objectives : This study was to analyze definitions of herbal medicinal preparations, crude drug preparations, and new drugs from natural products in the relevant laws and regulations, understand the related problems, and propose directions for improvement. Methods : I analyzed the legal definitions in respect of herbal medicinal preparations, crude drug preparations, and new drugs from natural products in relevant laws and regulations since 1945, explained the problems, and suggested the solution-considering the academic stance of Traditional Korean Medicine and the dualistic medical and pharmaceutical system. Results : Regarding the current laws and regulations that are relevant to herbal medicinal preparations, we should 1) clarify the boundaries between the duty of physicians and that of pharmacists, 2) limit the principles of Korean Medicine as well as the contents of the related textbooks, 3) find a way to protect the intellectual property rights for herbal medicinal preparations, and 4) establish a separate standard for drug classification regarding herbal medicinal preparations. In case of crude drug preparations, we should 1) clarify the meaning and limitations of the phrase, "the point of view of Western medicine," and 2) establish a classification standard for drugs that are used in Korean Medicine and clarify the boundaries between herbal drug preparations and crude drug preparations. Furthermore, laws and regulations apropos of new drugs from natural products do not actually fit the concept of "new drug," and due to subordinate laws, a supplement to a new drug submission is contradictorily misclassified as a new drug from natural products. Conclusions : The problems of legal definitions of herbal medicinal preparations, crude drug preparations, and new drugs from natural products have emerged in the process of giving approval to drugs that are made of herbs and natural products under the dualistic medical and pharmaceutical System. Laws and regulations that differentiate the process of approving herbs that are used in Korean Medicine and the others should be established.

주제어

#Herbal medicinal preparations   #Crude drug preparations   #Natural product new drug  

저자의 다른 논문

참고문헌 (31)

1. Yun-Kyung Kim.Sunyoung Cho.Jiyeon Kim.Yeonseok Kang. Semantic Change of Crude Drug Preparations in Korea and Policy Evaluation. Herbal Formula Science. 2013: 21(2);29-43.  원문보기 상세보기
2. Eom, Seok-Ki. A Study on the Changes in Legal Definition of Medicinal Products in the Relevant Laws and Regulations. Journal of Society of Preventive Korean Medicine. 2014: 18(1);23-41.  원문보기 상세보기
3. Eom, Seok-Ki. A study on the Problems and Improvement Proposals on Legal Definitions in Regards to Herbs, Herbal Drugs, Crude Drugs and Natural Products. J of Oriental Medical Classics. 2014;27(2):77-95.  원문보기 상세보기
4. Yun-Kyung Kim. The Standardization of Herbal Medicine Preparations in Korea. Report (11171.Herbal Medicine Policy Division.405). K.FDA. 2012. p.29, 276. 
5. Biopharmaceuticals and Herbal Medicine Bureau, Ministry of Food and Drug Safety. A Guide to Crude Drug Preparations/Herbal Medicinal Preparations, Regulation on Pharmaceuticals Approval, Notification and Review. Ministry of Food and Drug Safety. 2009. p.21, 28. 
6. Akomnews. "Pushing ahead with redefining the terms regarding herbal medicine." 2010.5.24. 
7. Akomnews. "Redefining the terms regarding herbal medicine came to a standstill." 2010.6.24. 
8. Akomnews. "Principle of herbal medicine." 2009. 11.16. 
9. The Kyunghyang Shinmun. "Crude drug preparations are more expensive than herbal medicine-Drug pricing and reimbursement of Korean Medicine, Notification of Ministry of Health." 1987.3.24. 
10. Akomnews. "Call for the expansion of insurance benefit of herbal medicine during the national inspection (Health Insurance Review & Assessment Service)." 2011.9.19 
11. Yakup.com. "The tension on FTA can be solved with 'Scientification of Korean Medicine." 2007. 4.28. 
12. Korea Pharmaceutical Association News. "The absence of the intellectual property is the first major cause of the recession in Korean Medicine market." 2008.4.24. 
13. MK Business News. "Disapproval of manufacturing crude medicinal preparations." 1967.4.27. 
14. MK Business News. "Permission of manufacturing crude medicinal preparations." 1968.7.5. 
15. MK Business News. "Promoting development of crude medicinal preparations-Ministry of Health decides to establish the Department of Crude Drugs." 1994.1.31. 
16. The Hankyoreh. "Pharmacists resist the transfer of duties regarding herbal medicine and demand the resignation of the minister." 1997.10.9. 
17. DongA Ilbo. "Ministry of Health and Welfare, transfers the duties regarding herbal medicine." 1997.12.20. 
18. MK Business News. "The term "new drug" is defined." 1977.12.24. 
19. MK Business News. "Promoting new drugs made from traditional medicine." 1986. 11.29. 
20. The Kyunghyang Shinmun. "Crude drug preparations are more expensive than herbal medicine-Drug pricing and reimbursement of Korean Medicine, Notification of Ministry of Health." 1987.3.24. 
21. MK Business News. "A new trend in pharmaceutical industry: Korean Medicine." 1988.9.5. 
22. The Hankyoreh. "19 companies that are specialized in crude drug preparations organize a conference." 1990.5.23. 
23. MK Business News. "The medicinal effect of Woowhangchongshimwon will be scientifically analyzed." 1991.9.6. 
24. The Hankyoreh. "Woowhangchong shimwon is not effective in treating angina and harden arteries; it's effective in treating stroke and hypertension." 1993. 12.18. 
25. Chemistry and Biotechnology Examination Bureau, Korean Intellectual Property Office. A Screening Guideline for Pharmaceuticals and Cosmetics. 2011. p.19, 20. 
26. The Association of Korean Medicine. Principles of Korean Medicine and Definitions of Terms that are Relevant to Herbal Medicinal Preparations. 2012.6. 
27. Ministry of Food and Drug Safety (Press Release). 2010 Approval Status of Investigational New Drug Application. 2011.2.25. 
28. Korea Law Information Center (http://www.law.go.kr/main.html) 
29. Electronic Gazette (http://gwanbo.korea.go.kr/main.gz) 
30. The Association of Korean Medicine (http://www.akom.org/main/) 
31. Korea Oriental Drug Association (http://kherb.org/html2/00_main/main.asp) 

이 논문을 인용한 문헌 (1)

1. Ku, Nam-Pyong ; Seol, Sung-Soo 2015. "Limits of Innovation in Korean Medicine Industry" 기술혁신학회지 = Journal of Korea technology innovation society, 18(4): 667~692  원문보기 상세보기